Drug delivery using platelet cancer cell interaction

Pharmaceutical Research

Volumn 30, Issue 11, 2013, Pages 2785-2794

  Sarkar, Sounik ^a   Alam, Mohammed Aftab ^a   Shaw, Jyoti ^a   Dasgupta, Anjan Kr ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

cancer cell line; doxorubicin; drug delivery; EAC; platelets

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD PLATELETS; CARCINOMA, EHRLICH TUMOR; CELL COMMUNICATION; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE;

EID: 84886087036     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1097-1     Document Type: Article

References (31)

1. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007;18:241-68.
2. Chonn A, Cullis PR. Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol. 1995;6:698-708.
3. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145-60.
4. Mufamadi MS, Pillay V, Choonara YE, Du Toit LC, Modi G, Naidoo D, et al. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv. 2011;2011:939851.
5. Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90:667-80.
6. Kozubek A, Gubernator J, Przeworska E, Stasiuk M. Liposomal drug delivery, a novel approach: plarosomes. Acta Biochim Pol. 2000;47:639-49.
7. Sharma US, Sharma A. Liposomes in drug delivery: progress and limitations. Curr Opin Biotechnol. 1997;154:123-40.
8. Mezei M, Foldvari M, Gesztes A, Cardinal L, Behl M, Kowalczyk I. Topical liposomal local anesthetics: design, optimization and evaluation of formulations. Drug Dev Ind Pharm. 1993;19:2499-517.
9. Nounou MM, El-Khordagui LK, Khalafallah NA, Khalil SA. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm. 2006;56:311-24.
10. Mohanraj VJ, Chen Y. Nanoparticles - a review. Trop J Pharm Res. 2006;5:561-73.
11. Patra HK, Dasgupta AK, Sarkar S, Biswas I, Chattopadhyay A. Dual role of nanoparticles as drug carrier and drug. Cancer Nanotechnol. 2011;2:37-47.
12. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20.
13. Li YF, Chen C. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small. 2011;7:2965-80.
14. Ahamed M, Alsalhi MS, Siddiqui MK. Silver nanoparticle applications and human health. Clin Chim Acta. 2010;411:1841-8.
15. Deb S, Chaterjee M, Bhattacharyay J, Lahiri P, Chaudhuri U, Pal Choudhuri S, et al. Role of purinergic receptors in platelet-nanoparticle interactions. Nanotoxicology. 2007;1:93-103.
16. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532-48.
17. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol. 1987;18:111-22.
18. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood. 1984;63:55-63.
19. Habermann BF. Targeting tumor cell-platelet interaction in breast cancer metastasis. Pathophysiol Haemost Thromb. 2003;33:56-8.
20. Nieswandt B, Hafner M, Echtenacher B, Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999;59:1295-300.
21. Deb S, Patra HK, Lahiri P, Dasgupta AK, Chakrabarti K, Chaudhuri U. Multistability in platelets and their response to gold nanoparticles. Nanomedicine. 2011;7:376-84.
22. Holmsen H, Day HJ, Stormorken H. The blood platelet release reaction. Scand J Haematol Suppl. 1969;8:3-26.
23. Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 1994;72:278-84.
24. Shattil SJ, Anaya-Galindo R, Bennett J, Colman RW, Cooper RA. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest. 1975;55:636-43.
25. White JG. Why human platelets fail to kill bacteria. Platelets. 2006;17:191-200.
26. White JG. Platelets are covercytes, not phagocytes: uptake of bacteria involves channels of the open canalicular system. Platelets. 2005;16:121-31.
27. Bhattacharyya A, Choudhuri T, Pal S, Chattopadhyay S, Datta GK, Sa G, et al. Apoptogenic effects of black tea on ehrlich's ascites carcinoma cell. Carcinogenesis. 2003;24:75-80.
28. Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T, et al. Mechanisms of curcumin-induced apoptosis of ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun. 2001;288:658-65.
29. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of dna damage in individual cells. Exp Cell Res. 1988;175:184-91.
30. Ardlie NG, Packham MA, Mustard JF. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol. 1970;19:7-17.
31. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF. Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2:544-68.